Malaria Drug Resistance and Treatment Access
Through the University of Maryland Center for Vaccine Development and the Malaria Alert Centre in Blantyre Malawi, Dr. Frosch studied changing malaria resistance patterns and the relationship to national endorsed malaria treatment guidelines. In recent years, the frequency of malaria cases in the United States continues to rise. Hennepin Healthcare System sees more of these patients than any other hospital in Minnesota. With our experience in malaria treatment and prevention, we have worked with community partners to ensure safe and affordable access to antimalarial treatments and advocated to increase access to these lifesaving medications for patients in our community.
Key Publications
Frosch AE, Thielen BK, Alpern JD, Walz EJ, Volkman HR, Smith M, Wanduragala D, Holder W, Boumi AE, Stauffer WM. Antimalarial chemoprophylaxis and treatment in the USA: limited access and extreme price variability. J Travel Med. 2022 Jul 14;29(4). doi: 10.1093/jtm/taab117. PubMed PMID: 34343310; PubMed Central PMCID: PMC9282095.
Frosch AE, Laufer MK, Mathanga DP, Takala-Harrison S, Skarbinski J, Claassen CW, Dzinjalamala FK, Plowe CV. Return of widespread chloroquine-sensitive Plasmodium falciparum to Malawi. J Infect Dis. 2014 Oct 1;210(7):1110-4. doi: 10.1093/infdis/jiu216. Epub 2014 Apr 9. PubMed PMID: 24723474; PubMed Central PMCID: PMC6281358.
Frosch AE, Venkatesan M, Laufer MK. Patterns of chloroquine use and resistance in sub-Saharan Africa: a systematic review of household survey and molecular data. Malar J. 2011 May 9;10:116. doi: 10.1186/1475-2875-10-116. PubMed PMID: 21554692; PubMed Central PMCID: PMC3112453.
Key Collaborators
